Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: The baltimore longitudinal study of aging

Journal of Nutrition, Health and Aging

Volumn 14, Issue 7, 2010, Pages 507-513

  Semba, Richard D ^a   Beck, J ^a   Sun, K ^a   Egan, J M ^b   Carlson, O D ^b   Varadhan, R ^a   Ferrucci, L ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Advanced glycation end products; aging; diabetes; glucose tolerance

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; GLUCOSE;

ADULT; AGED; AGING; AMINO ACID BLOOD LEVEL; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 77957941778     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-010-0105-y     Document Type: Article

References (31)

1. G. Basta A.M. Schmidt R. de Caterina 2004 Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc. Res 63 582 592 1:CAS:528:DC%2BD2cXmslertLc%3D 10.1016/j.cardiores.2004.05.001 15306213 (Pubitemid 39078671)
2. T.J. Berg J.T. Clausen P.A. Torjesen K. Dahl-Jørgensen H.J. Bangstad K.F. Hanssen 1998 The advanced glycation end product N (carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes Diabetes Care 21 1997 2002 1:STN:280:DyaK1M%2FhslOmtQ%3D%3D 10.2337/diacare.21.11.1997 9802757 (Pubitemid 28478307)
3. B.O. Boehm S. Schilling S. Rosinger G.E. Lang G.K. Lang R. Kietsch-Engel P. Stahl 2004 Elevated serum levels of N -carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema Diabetologia 47 1376 1379 1:CAS:528:DC%2BD2cXmtlylsbc%3D 10.1007/s00125-004-1455-y 15258735 (Pubitemid 39232422)
4. J.M. Bohlender S. Franke G. Stein G. Wolf 2005 Advanced glycation end products and the kidney Am. J. Renal Physiol 289 F645 F659 1:CAS:528: DC%2BD2MXhtFensb3E 10.1152/ajprenal.00398.2004 (Pubitemid 41324185)
5. M. Busch S. Franke G. Wolf A. Brandstädt U. Ott J. Gerth G.L. Hunsicker G. Stein 2006 The advanced glycation end product N -carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension Am. J. Kidney Dis 48 571 579 1:CAS:528:DC%2BD28XhtFGrtbzL 10.1053/j.ajkd.2006.07.009 16997053 (Pubitemid 44425379)
6. Expert Committee on the DiagnosisClassification of Diabetes Mellitus. 2003 Followup report on the diagnosis of diabetes mellitus Diabetes Care 26 3160 3136 10.2337/diacare.26.11.3160 (Pubitemid 37339514)
7. Expert Panel on Detection, Evaluation,Treatment of High Blood Cholesterol in Adults. 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2486 2497 10.1001/jama.285.19.2486
8. W.T. Friedewald R.I. Levy D.S. Frederikson 1972 Estimation of the concentration of lowdensity-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem 18 499 502 1:CAS:528: DyaE38Xkslagsbw%3D 4337382
9. T. Goldberg W. Cai M. Peppa V. Dardaine B.W. Baliga J. Uribarri H. Vlassara 2004 Advanced glycoxidation end products in commonly consumed foods J. Am. Diet. Assoc 104 1287 1291 1:CAS:528:DC%2BD2cXntV2ktL4%3D 10.1016/j.jada.2004.05.214 15281050 (Pubitemid 39036519)
10. K. Hirata K. Kubo 2004 Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes Endocrine J 51 537 544 1:CAS:528:DC%2BD2MXislOjs7c%3D 10.1507/endocrj.51.537 (Pubitemid 40209020)
11. J.S. Hwang C.H. Shin S.W. Yang 2005 Clinical implications of N (carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes Diabetes Obes. Metab 7 263 267 1:CAS:528:DC%2BD2MXktlWqt7g%3D 10.1111/j.1463-1326.2004.00398.x 15811143 (Pubitemid 40542817)
12. P.T. James R. Leach E. Kalamara M. Shayeghi 2001 The worldwide obesity epidemic Obes. Res 9 suppl4 228S 233S 10.1038/oby.2001.123 11707546
13. B.K. Kilhovd T.J. Berg K.I. Birkeland P. Thorsby K.F. Hanssen 1999 Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease Diabetes Care 22 1543 1548 1:STN:280:DyaK1MvgvVCjsg%3D%3D 10.2337/diacare.22.9.1543 10480523 (Pubitemid 29418253)
14. T. Koschinsky C.J. He T. Mitsuhashi R. Bucala C. Liu C. Buenting K. Heitmann H. Vlassara 1997 Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy Proc. Natl. Acad. Sci. USA 94 6474 6479 1:CAS:528:DyaK2sXjvFGhu7g%3D 10.1073/pnas.94.12.6474 9177242 (Pubitemid 27270709)
15. A.S. Levey J.P. Bosch J.B. Lewis T. Greene N. Rogers D. Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann. Intern. Med 130 461 470 1:CAS:528: DyaK1MXitFChs7k%3D 10075613
16. C.J.A.L. Mentink B.K. Kilhovd G.J.W.M. Rondas-Colbers P.A. Torjesen B.H.R. Wolffenbuttel 2006 Time course of specific AGEs during optimized glycaemic control in type 2 diabetes Netherlands J. Med 64 10 16 1:CAS:528:DC%2BD28XhvVWisrs%3D
17. J. Miura S.I. Yamagishi Y. Uchigata M. Takeuchi H. Yamamoto Z. Makita Y. Iwamoto 2003 Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes J. Diabet. Compl 17 16 21 10.1016/S1056-8727(02) 00183-6 (Pubitemid 36042787)
18. M. Negrean A. Stirban B. Stratmann T. Gawlowski T. Horstmann C. Götting K. Kleesiek M. Mueller-Roesel T. Koschinsky J. Uribarri H. Vlassara D. Tschoepe 2007 Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am. J. Clin. Nutr 85 1236 1243 1:CAS:528:DC%2BD2sXls1Kiur4%3D 17490958
19. Y. Ono S. Aoki K. Ohnishi T. Yasuda K. Kawano Y. Tsukada 1998 Increased serum levels of advanced glycation end-products and diabetic complications Diabetes Res. Clin. Pract 41 131 137 1:CAS:528:DyaK1cXlsFCitrs%3D 10.1016/S0168-8227(98)00074-6 9789719 (Pubitemid 28459016)
20. S. Reddy J. Bichler K.J. Wells-Knecht S.R. Thorpe J.W. Baynes 1995 N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins Biochemistry 34 10872 10878 1:CAS:528: DyaK2MXnsVKrtbY%3D 10.1021/bi00034a021 7662668
21. C.G. Schalkwijk A. Baidoshvili C.D. Stehouwer V.W. van Hinsbergh H.W. Niessen 2004 Increased accumulation of the glycoxidation product N (carboxymethyl)lysine in hearts of diabetic patients: generation and characterization of a monoclonal anti-CML antibody Biochim. Biophys. Acta 1636 82 89 1:CAS:528:DC%2BD2cXivVylu7o%3D 15164755
22. Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L. Plasma carboxymethyllysine, and advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults. J Am Geriatr Soc 2009;Aug 13 [Epub ahead of print].
23. R.D. Semba J.C. Fink K. Sun S. Bandinelli J.M. Guralnik L. Ferrucci 2009 Carboxymethyllysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults Eur J Nutr 48 38 44 1:CAS:528:DC%2BD1MXhtVCmt7o%3D 10.1007/s00394-008-0757-0 19031098
24. P.S. Sharp S. Rainbow S. Mukherjee 2003 Serum levels of low molecular weight advanced glycation end products in diabetic subjects Diabet. Med 20 575 579 1:CAS:528:DC%2BD3sXmsV2mtr8%3D 10.1046/j.1464-5491.2003.00973.x 12823240 (Pubitemid 36886473)
25. Shock NW, Greulich RC, Andres RA, Arenberg D, Casta PT, Lakatta EG, Tobin JP. Normal Human Aging: the Baltimore Longitudinal Study of Aging. Washington, D.C., U.S. Government Printing Office, 1984.
26. K.C.B. Tan W.S. Chow V.H.G. Ai C. Metz R. Bucala K.S.L. Lam 2002 Advanced glycation end products and endothelial dysfunction in type 2 diabetes Diabetes Care 25 1055 1059 1:CAS:528:DC%2BD38XkslSksLY%3D 10.2337/diacare.25.6.1055 12032114 (Pubitemid 41110493)
27. J. Uribarri W. Cai M. Peppa S. Goodman L. Ferrucci G. Striker H. Vlassara 2007 Circulating glycotoxins and dietary advanced glyation endproducts: two links to inflammatory response, oxidative stress, and aging J. Gerontol. A Biol. Sci. Med. Sci 72 427 433
28. J. Uribarri M. Peppa W. Cai T. Goldberg M. Lu S. Baliga J.A. Vassalotti H. Vlassara 2003 Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients Am. J. Kidney Dis 42 532 538 1:CAS:528:DC%2BD3sXnsleisb8%3D 10.1016/S0272-6386(03)00779-0 12955681 (Pubitemid 37048129)
29. H. Vlassara G. Striker 2007 Glycotoxins in the diet promote diabetes and diabetic complications Curr. Diabetes Rep 7 235 241 1:CAS:528:DC%2BD2sXhtVentbvN 10.1007/s11892-007-0037-z (Pubitemid 46951921)
30. G. Warnick J. Benderson J. Albers 1982 Dextran sulfate-Mg2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol Clin. Chem 28 1379 1388 1:CAS:528:DyaL38Xks1yrtbs%3D 7074948
31. X. Zhang M. Frischmann R. Kientsch-Engel K. Steinmann H. Stopper T. Niwa M. Pischetsrieder 2005 Two immunochemical assays to measure advanced glycation endproducts in serum from dialysis patients Clin. Chem. Lab. Med 43 503 511 1:CAS:528:DC%2BD2MXkvFGgtbY%3D 10.1515/CCLM.2005.089 15899672 (Pubitemid 41460627)